Three major companies have raised their fiscal year 2026 guidance following strong quarterly earnings, signaling confidence in their business outlooks. BWX Technologies, Johnson & Johnson, and UnitedHealth Group all reported solid financial results, prompting management to upgrade their forecasts.
BWX Technologies, which provides nuclear components and services, saw revenue rise 18% year-over-year to $901.6 million. Commercial Operations sales surged 72% to $302.5 million. The company raised its adjusted EPS guidance to $4.70, $4.80 per share and increased its free cash flow outlook to $345, $360 million.
Johnson & Johnson reported a 5.9% year-over-year sales increase to $25.4 billion. Its Innovative Medicine business grew 7.7% to roughly $16.8 billion. Management raised its adjusted EPS outlook by $0.06 at the midpoint to $11.10 per share and increased its expected annual sales to $101.2 billion at the midpoint.
UnitedHealth Group, which has faced challenges with elevated medical costs, showed improvement in its latest quarter. The company's medical care ratio fell to 88.4% from 89.9% in the same period last year, and operating earnings climbed to $6.6 billion from $4.3 billion. Management raised its adjusted EPS outlook to at least $20.50 per share, up from the prior $19.50, $20.00 range.